Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Ophthalmic Artery Doppler to predict labor problems before induction

Official title: OPHthalmic artEry DoppLer Evaluation After 37 Weeks of Gestation and Intrapartum Fetal Adverse Outcomes (the OPHELIA Study)

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07846137 · Data updated 2026-11-12

This study tests whether measuring the ophthalmic artery Doppler in pregnant people at term who are being induced can help predict intrapartum fetal distress.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment1477 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Rome, rm)
StatusRecruiting
StartedSeptember 18, 2026
Main results expectedJune 15, 2027
Study endsJanuary 31, 2028
Registry record updatedOctober 30, 2026
Trial IDNCT07846137 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant individuals aged 18 or older at or beyond 37 weeks of gestation who are planned for induction of labor and able to give informed consent.

Probably not a fit

Patients not showing placental dysfunction or not experiencing intrapartum distress may not derive specific benefit from this testing.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study investigates the ophthalmic artery Doppler as a potential soft marker of placental insufficiency in patients undergoing induction of labor after 37 weeks. By analyzing the Doppler waveform, particularly the PSV2/PSV1 ratio, researchers aim to see if changes correlate with adverse intrapartum fetal outcomes. The trial is conducted at a single Italian center and involves inducing labor under standard obstetric care with careful intrapartum monitoring. The goal is to determine if OA Doppler can complement existing assessments to identify fetuses at higher risk for hypoxic stress during labor.

Why it matters

Potential benefit: If successful, OA Doppler could provide an early, noninvasive indicator of placental insufficiency to help tailor labor management and improve fetal outcomes.

How similar studies have gone: Previous observational studies have suggested OA Doppler may relate to placental dysfunction, but prospective interventional data are limited and further validation is needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Pregnant patients after 37 weeks of gestation undergoing induction of labor
* Ability to provide written informed consent

Exclusion Criteria:

* Age \<18 years
* Known fetal malformations
* Known fetal genetic syndromes
* Multiple pregnancy
* Known maculopathies
* Inability or unwillingness to provide written informed consent

Where it's running

  • Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
    Rome, rm, Italy
    Recruiting

Study contacts

  • Principal investigator: Tullio Ghi — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • Study coordinator: Tullio Ghi, MD PhD
  • Email: tullio.ghi@unicatt.it
  • Phone: +393385070025

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.